Groups | Patient group I | Patient group II |
---|---|---|
ACR criteria, median (min-max) | 6 (4–10) | 5 (4–10) |
Malar rash (%) | 67 | 52 |
Discoid rash (%) | 37 | 20 |
Photosensitivity (%) | 71 | 56 |
Oral ulcers (%) | 27 | 26 |
Arthritis (%) | 87 | 80 |
Serositis (%) | 61 | 41 |
Renal disease (%) | 42 | 34 |
Neurological disorder (%) | 9 | 6 |
Hematological manifestations (%) | 65 | 56 |
Leukopenia (%) | 43 | 37 |
Lymphopenia (%) | 33 | 26 |
Thrombocytopenia (%) | 24 | 15 |
Immunology (%) | 80 | 71 |
Anti-dsDNA antibodies (%) | 74 | 61 |
Anti-Smith antibodies (%) | 8 | 9 |
ANA (%) | 99 | 98 |
SLICC-DI scorea, median (min–max) | 2 (0–9) | 1 (0–8) |